FUNDING · STARTUPS · #863
Basecamp Research raises $140M to scale EDEN biological AI and Trillion Gene Atlas
Basecamp Research said it raised $140 million from investors including S32, Nvidia, Anthropic's Anthology Fund, the NATO Innovation Fund and Redalpine to develop its EDEN biological AI models and advance cell‑therapy candidates. The company trains EDEN on environmental genomic data (BaseData/Trillion Gene Atlas), reports a current dataset of ~15 trillion nucleotides and says the first EDEN generation trained on 9.7 trillion tokens, but only preclinical (mouse) results exist so far.
KEY POINTS
- Basecamp Research said it raised $140 million from investors including S32, Nvidia, Anthropic's Anthology Fund, the NATO Innovation Fund and Redalpine to develop its EDEN biological AI models and advance cell‑therapy candidates.
- The company trains EDEN on environmental genomic data (BaseData/Trillion Gene Atlas), reports a current dataset of ~15 trillion nucleotides and says the first EDEN generation trained on 9.7 trillion tokens, but only preclinical (mouse) results exist so far.
- The funding and major AI/cloud backers accelerate efforts to assemble far larger, diverse genomic datasets and train biology‑focused models that could materially change drug discovery, though human efficacy remains unproven.
WHY IT MATTERS
The funding and major AI/cloud backers accelerate efforts to assemble far larger, diverse genomic datasets and train biology‑focused models that could materially change drug discovery, though human efficacy remains unproven.